Impact of Perioperative Allogenic Bloodtransfusions on Recurrence and Metastasis Rates in Patients with surgically treated Oral Squamous Cell Carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008576

Enrollment

472

Registered

2015-05-26

Start date

2015-04-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C14 C31

Interventions

Group 1: Retrospektive analysis of recurrences and mortality in surgically treated OSCC cases in regard to allogenic blood transfusions.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: primary surgical treatment from January 1st 2000 to June 30th 2014 in patients with primary OSCC

Exclusion criteria

Exclusion criteria: malignancies other than OSCC, extraoral location of tumor, primary non-surgical therapy (radio-chemotherapy), secondary OSCC or CUP syndrome

Design outcomes

Primary

Measure	Time frame
Time to recurrence or distant metastasis.	—

Secondary

Measure	Time frame
Rate of allogenic blood transfusions in recurrence and mortality.	—

Countries

Germany

Contacts

Public ContactMichael Ermer

Uniklinik Freiburg Klinik für MKG Chirurgie

michael.ermer@uniklinik-freiburg.de076127047010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026